G. Çaltepe

Impact of CFTR modulators on respiratory support requirements and lung transplant candidacy status in advanced cystic fibrosis lung disease: data from the cystic fibrosis registry of Turkey

B. Sunman, E. Altay Tanyer, E. Yalçın, V. Şen et autres

Predictors of cystic fibrosis-related liver disease: data from cystic fibrosis registry of Turkey

B. Sunman, E. Gümüş, Ö.F. İpek, V. Şen et autres

P005 Seven-year follow-up of patients with cystic fibrosis after newborn screening program

Handan Kekeç, Tuğba Şişmanlar Eyüboğlu, Ayşe Tana Aslan, Zeynep İlkşen Hocoğlu et autres

tr, us (code pays fourni par la source)

P031 Determining the genotypic and phenotypic characteristics of patients in the Turkish National Cystic Fibrosis Registry System

Nilgün Kula, Ayşe Tana Aslan, Tuğba Şişmanlar Eyüboğlu, Zeynep İlkşen Hocoğlu et autres

tr, us (code pays fourni par la source)

One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?

S Uytun, Şehrinaz Polat, Satı Özkan Tabakçı, G Cinel et autres

Objectives: It is shown that modulatory therapies(MT) in cystic fibrosis(CF) positively affect pulmonary function tests(PFT) parameters,patients’ weight gain, decreasing lung infections and lung-related deaths and improving quality of life. Many CF patients cannot reach MT in our country. This study aims to …

tr (code pays fourni par la source)

P060 Factors associated with pulmonary functions of cystic fibrosis (CF) patients in the National Cystic Fibrosis Patient Registry: a retrospective cohort study

N. Çobanogĝlu, Nagehan Emiralioğlu, Beyza Oktay Cakir, A. Sertçelik et autres